-
1دورية أكاديمية
المؤلفون: Korman, AJ, Marusic-Galesic, S, Spencer, D, Kruisbeek, AM, Raulet, DH
المصدر: Journal of Experimental Medicine. 168(3)
مصطلحات موضوعية: Genetics, Amino Acid Sequence, Animals, Base Sequence, Blotting, Southern, Cloning, Molecular, DNA, Genes, Hybridomas, Mice, Multigene Family, Receptors, Antigen, T-Cell, Receptors, Antigen, T-Cell, gamma-delta, Restriction Mapping, T-Lymphocytes, Thymus Gland, Medical and Health Sciences, Immunology
وصف الملف: application/pdf
URL الوصول: https://escholarship.org/uc/item/3599g6vg
-
2
المؤلفون: Aznar, MA, Labiano, S, Diaz-Lagares, A, Molina, C, Garasa, S, Azpilikueta, A, Etxeberria, I, Sanchez-Paulete, AR, Korman, AJ, Esteller, M, Sandoval, J, Melero, I
المصدر: Cancer Immunology Research
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instnameURL الوصول: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::58970634085747bf79f5fd8172a737d0
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=9646 -
3دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
4دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
5
-
6دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
7دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
8دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
9دورية أكاديمية
المؤلفون: Dorel R; Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States., Sun D; Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States., Carruthers N; Convelo Therapeutics, 11000 Cedar Avenue, Cleveland, Ohio 44106, United States., Castanedo GM; Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States., Ung PM; Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States., Factor DC; Convelo Therapeutics, 11000 Cedar Avenue, Cleveland, Ohio 44106, United States., Li T; Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States., Baumann H; Convelo Therapeutics, 11000 Cedar Avenue, Cleveland, Ohio 44106, United States., Janota D; Convelo Therapeutics, 11000 Cedar Avenue, Cleveland, Ohio 44106, United States., Pang J; Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States., Salphati L; Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States., Meklemburg R; Convelo Therapeutics, 11000 Cedar Avenue, Cleveland, Ohio 44106, United States., Korman AJ; Convelo Therapeutics, 11000 Cedar Avenue, Cleveland, Ohio 44106, United States., Harper HE; Convelo Therapeutics, 11000 Cedar Avenue, Cleveland, Ohio 44106, United States., Stubblefield S; Convelo Therapeutics, 11000 Cedar Avenue, Cleveland, Ohio 44106, United States., Payandeh J; Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States., McHugh D; Convelo Therapeutics, 11000 Cedar Avenue, Cleveland, Ohio 44106, United States., Lang BT; Convelo Therapeutics, 11000 Cedar Avenue, Cleveland, Ohio 44106, United States., Tesar PJ; Convelo Therapeutics, 11000 Cedar Avenue, Cleveland, Ohio 44106, United States., Dere E; Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States., Masureel M; Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States., Adams DJ; Convelo Therapeutics, 11000 Cedar Avenue, Cleveland, Ohio 44106, United States., Volgraf M; Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States., Braun MG; Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States.
المصدر: Journal of medicinal chemistry [J Med Chem] 2024 Mar 28; Vol. 67 (6), pp. 4819-4832. Date of Electronic Publication: 2024 Mar 12.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE
مواضيع طبية MeSH: Brain* , Hydantoins*/metabolism, Humans ; Oligodendroglia/metabolism ; Drug Design
-
10دورية أكاديمية
المؤلفون: Brahmer JR; From the Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Henry Ford Health Systems, Detroit, MI; Carolina BioOncology Institute, Huntersville, NC; Washington University School of Medicine Siteman Cancer Center, St Louis, MO; and Medarex, Bloomsbury, NJ, and Milpitas, CA., Drake CG; From the Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Henry Ford Health Systems, Detroit, MI; Carolina BioOncology Institute, Huntersville, NC; Washington University School of Medicine Siteman Cancer Center, St Louis, MO; and Medarex, Bloomsbury, NJ, and Milpitas, CA., Wollner I; From the Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Henry Ford Health Systems, Detroit, MI; Carolina BioOncology Institute, Huntersville, NC; Washington University School of Medicine Siteman Cancer Center, St Louis, MO; and Medarex, Bloomsbury, NJ, and Milpitas, CA., Powderly JD; From the Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Henry Ford Health Systems, Detroit, MI; Carolina BioOncology Institute, Huntersville, NC; Washington University School of Medicine Siteman Cancer Center, St Louis, MO; and Medarex, Bloomsbury, NJ, and Milpitas, CA., Picus J; From the Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Henry Ford Health Systems, Detroit, MI; Carolina BioOncology Institute, Huntersville, NC; Washington University School of Medicine Siteman Cancer Center, St Louis, MO; and Medarex, Bloomsbury, NJ, and Milpitas, CA., Sharfman WH; From the Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Henry Ford Health Systems, Detroit, MI; Carolina BioOncology Institute, Huntersville, NC; Washington University School of Medicine Siteman Cancer Center, St Louis, MO; and Medarex, Bloomsbury, NJ, and Milpitas, CA., Stankevich E; From the Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Henry Ford Health Systems, Detroit, MI; Carolina BioOncology Institute, Huntersville, NC; Washington University School of Medicine Siteman Cancer Center, St Louis, MO; and Medarex, Bloomsbury, NJ, and Milpitas, CA., Pons A; From the Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Henry Ford Health Systems, Detroit, MI; Carolina BioOncology Institute, Huntersville, NC; Washington University School of Medicine Siteman Cancer Center, St Louis, MO; and Medarex, Bloomsbury, NJ, and Milpitas, CA., Salay TM; From the Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Henry Ford Health Systems, Detroit, MI; Carolina BioOncology Institute, Huntersville, NC; Washington University School of Medicine Siteman Cancer Center, St Louis, MO; and Medarex, Bloomsbury, NJ, and Milpitas, CA., McMiller TL; From the Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Henry Ford Health Systems, Detroit, MI; Carolina BioOncology Institute, Huntersville, NC; Washington University School of Medicine Siteman Cancer Center, St Louis, MO; and Medarex, Bloomsbury, NJ, and Milpitas, CA., Gilson MM; From the Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Henry Ford Health Systems, Detroit, MI; Carolina BioOncology Institute, Huntersville, NC; Washington University School of Medicine Siteman Cancer Center, St Louis, MO; and Medarex, Bloomsbury, NJ, and Milpitas, CA., Wang C; From the Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Henry Ford Health Systems, Detroit, MI; Carolina BioOncology Institute, Huntersville, NC; Washington University School of Medicine Siteman Cancer Center, St Louis, MO; and Medarex, Bloomsbury, NJ, and Milpitas, CA., Selby M; From the Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Henry Ford Health Systems, Detroit, MI; Carolina BioOncology Institute, Huntersville, NC; Washington University School of Medicine Siteman Cancer Center, St Louis, MO; and Medarex, Bloomsbury, NJ, and Milpitas, CA., Taube JM; From the Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Henry Ford Health Systems, Detroit, MI; Carolina BioOncology Institute, Huntersville, NC; Washington University School of Medicine Siteman Cancer Center, St Louis, MO; and Medarex, Bloomsbury, NJ, and Milpitas, CA., Anders R; From the Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Henry Ford Health Systems, Detroit, MI; Carolina BioOncology Institute, Huntersville, NC; Washington University School of Medicine Siteman Cancer Center, St Louis, MO; and Medarex, Bloomsbury, NJ, and Milpitas, CA., Chen L; From the Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Henry Ford Health Systems, Detroit, MI; Carolina BioOncology Institute, Huntersville, NC; Washington University School of Medicine Siteman Cancer Center, St Louis, MO; and Medarex, Bloomsbury, NJ, and Milpitas, CA., Korman AJ; From the Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Henry Ford Health Systems, Detroit, MI; Carolina BioOncology Institute, Huntersville, NC; Washington University School of Medicine Siteman Cancer Center, St Louis, MO; and Medarex, Bloomsbury, NJ, and Milpitas, CA., Pardoll DM; From the Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Henry Ford Health Systems, Detroit, MI; Carolina BioOncology Institute, Huntersville, NC; Washington University School of Medicine Siteman Cancer Center, St Louis, MO; and Medarex, Bloomsbury, NJ, and Milpitas, CA., Lowy I; From the Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Henry Ford Health Systems, Detroit, MI; Carolina BioOncology Institute, Huntersville, NC; Washington University School of Medicine Siteman Cancer Center, St Louis, MO; and Medarex, Bloomsbury, NJ, and Milpitas, CA., Topalian SL; From the Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Henry Ford Health Systems, Detroit, MI; Carolina BioOncology Institute, Huntersville, NC; Washington University School of Medicine Siteman Cancer Center, St Louis, MO; and Medarex, Bloomsbury, NJ, and Milpitas, CA.
المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Feb 01; Vol. 41 (4), pp. 715-723.
نوع المنشور: Journal Article; Clinical Trial, Phase I; Research Support, Non-U.S. Gov't; Multicenter Study
بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: PubMed not MEDLINE; MEDLINE